Dopamine D4-receptor modulation of cortical neuronal network activity and emotional processing: Implications for neuropsychiatric disorders.
Dopamine (DA) transmission within cortical and subcortical structures is involved critically in the processing of emotionally relevant sensory information. Three interconnected neural regions, the medial prefrontal cortex (mPFC), basolateral nucleus of the amygdala (BLA) and the ventral tegmental area (VTA) have received considerable experimental attention, both in animal and clinical research models, as essential interconnected processors of emotional information. Neuronal network activity within both the mPFC and BLA are strongly modified by DA inputs from the VTA through both DA D(2)-like and D(1)-like receptors. However, emerging evidence from clinical, genetic, behavioral and electrophysiological investigations demonstrates a critical role for the DA D(4)-receptor subtype as a crucial modulator of emotional memory encoding and expression, both at the level of the single neuron, and at the systems level. In this review, we will examine recent evidence at the neuronal, behavioral and genetic levels of analysis that increasingly demonstrates an important role for DA D(4) transmission within cortical and subcortical emotional processing circuits. We will present evidence and some theoretical frameworks suggesting how disturbances in D(4)-receptor related neural circuitry may be involved in the neuropathological manifestations common in many neuropsychiatric disorders including schizophrenia, attention-deficit hyperactivity disorder (ADHD) and addiction.
Lauzon
Nicole M
NM
Department of Anatomy & Cell Biology, The Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario N6A 5C1, Canada.
Laviolette
Steven R
SR
D000818:Animals; D001522:Behavior, Animal; D002540:Cerebral Cortex / Q000166:cytology / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism / Q000494:pharmacology; D015259:Dopamine Agents / Q000494:pharmacology; D004644:Emotions / Q000502:physiology*; D006801:Humans; D007858:Learning / Q000187:drug effects / Q000502:physiology; D001523:Mental Disorders / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D008954:Models, Biological; D009415:Nerve Net / Q000503:physiopathology*; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D050638:Receptors, Dopamine D4 / Q000235:genetics / Q000378:metabolism*
D015259:Dopamine Agents; D050638:Receptors, Dopamine D4; D004298:Dopamine